Clinical TrialsSearch results
Number of results: 328
Completed
- Interventional, exploratory, open-label trial of Lu AF28996 in Japanese men and women with Parkinson's disease
- Parkinson's disease
- Yazawa Masanari
- 2023-08-12
Completed
- Randomized trial of Gorei-san enteroclysis
- Infectious gastroenteritis
- Niino Ryoji
- 2019-03-22
Completed
- Safety verification of robot-assisted laparoscopic resection for transverse colon cancer
- Transverse colon cancer
- Ogi Yusuke
- 2022-01-09
Completed
- Study of BUT measurement method
- Dry eye disease
- Sakane Yuri
- 2022-05-30
Recruiting
- A Phase I, Open label, Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Anti tumor Effects of Recombinant Oncolytic Virus M1 (M1 c6v1) for Treatment of Patients with Locally Advanced or Metastatic Solid Tumors
- Solid Tumors
- Sawai Yoshihito
- 2023-12-15
Recruiting
- A phase II randomized trial of adjuvant chemotherapy for the patients completely resected pathological stage IB(T>5cm), II, IIIA Non Small Cell Lung Cancer comparing S-1 / S-1 with CDDP
- non-small cell lung cancer
- Kyushu University,Graduate School of Medical Science,Department of Surgery and Science
- 2009-03-12
Recruiting
- A Phase III, Randomised, Double-blind, Placebo-controlled, Multicentre, International Study of Durvalumab Plus Domvanalimab(AB154) in Participants With Locally Advanced (Stage III), Unresectable Non-small Cell Lung Cancer Whose Disease Has Not Progressed Following Definitive Platinum-based Concurrent Chemoradiation Therapy
- Non-Small Cell Lung Cancer
- Yamaji Shigeyuki
- 2022-03-23
Recruiting
- A Randomised phase III clinical trial of combined therapy with CPT-11/CDDP versus CPT-11 alone in patients with advaneced or recurrent gastric cancer resistant to S-1
- Gastric Cancer
- ECRIN
- 2009-10-01
Recruiting
- A Study of Dato-DXd Versus Investigator's Choice Chemotherapy in Patients With Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer, Who Are Not Candidates for PD-1/PD-L1 Inhibitor Therapy
- Breast Cancer
- Inoguchi Akihiro
- 2022-06-09
Recruiting
- A Study of Zanidatamab in Combination With Chemotherapy Plus or Minus Tislelizumab in Patients With HER2-positive Advanced or Metastatic Gastric and Esophageal Cancers (HERIZON-GEA-01)
- advanced or metastatic GEA, including gastric, GEJ, and esophageal adenocarcinomas.
- Sakanishi Ryuichi
- 2023-06-19